Plasmatic Inactive IL-18 Predicts a Worse Overall Survival for Advanced Non-Small-Cell Lung Cancer with Early Metabolic Progression after Immunotherapy Initiation
血浆中无活性的 IL-18 预示着免疫治疗开始后早期代谢进展的晚期非小细胞肺癌患者总体生存率较差
期刊:Cancers
影响因子:
doi:10.3390/cancers16122226
Serena Janho Dit Hreich, Olivier Humbert, Tanguy Pacé-Loscos, Renaud Schiappa, Thierry Juhel, Marius Ilié, Victoria Ferrari, Jonathan Benzaquen, Paul Hofman, Valérie Vouret-Craviari
